Hainan Shuangcheng Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 3/6
Hainan Shuangcheng Pharmaceuticals has a total shareholder equity of CN¥466.3M and total debt of CN¥209.2M, which brings its debt-to-equity ratio to 44.9%. Its total assets and total liabilities are CN¥824.6M and CN¥358.3M respectively.
Key information
44.9%
Debt to equity ratio
CN¥209.23m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥50.25m |
| Equity | CN¥466.28m |
| Total liabilities | CN¥358.28m |
| Total assets | CN¥824.56m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 002693's short term assets (CN¥159.2M) do not cover its short term liabilities (CN¥159.9M).
Long Term Liabilities: 002693's short term assets (CN¥159.2M) do not cover its long term liabilities (CN¥198.4M).
Debt to Equity History and Analysis
Debt Level: 002693's net debt to equity ratio (34.1%) is considered satisfactory.
Reducing Debt: 002693's debt to equity ratio has increased from 27.8% to 44.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 002693 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 002693 has sufficient cash runway for 2.3 years if free cash flow continues to reduce at historical rates of 29.1% each year.